US Broker Ratings

Fortrea Holdings Inc. (FTRE) Investor Outlook: Navigating a 52-Week High with Strategic Collaborations

Fortrea Holdings Inc. (NASDAQ: FTRE), a burgeoning player in the healthcare sector, specifically within the biotechnology industry, presents a multifaceted proposition to investors. With a market capitalization of $1.61 billion,..

Kamada Ltd. (KMDA) Stock Analysis: Unpacking a 63.52% Potential Upside in Healthcare Innovation

Kamada Ltd. (NASDAQ: KMDA), a prominent player in the healthcare sector, is generating buzz among investors due to its compelling potential upside of 63.52%. As a specialist in plasma-derived protein..

Autolus Therapeutics (AUTL): Biotech Stock Poised for a 404% Upside with Strong Buy Ratings

The biotechnology sector often captures investor interest with its potential for groundbreaking medical innovations, and Autolus Therapeutics plc (NASDAQ: AUTL) is no exception. Headquartered in London, this clinical-stage biopharmaceutical company..

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: A Biotech Gem with 148% Upside Potential

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) is making waves in the biotechnology sector, offering a tantalizing prospect for investors seeking high-growth opportunities in healthcare. With a market capitalization of $822.94 million,..

SIGA Technologies Inc. (SIGA) Stock Analysis: A Deep Dive into Its Healthcare Prospects and Valuation

SIGA Technologies Inc. (NASDAQ: SIGA), a notable player in the healthcare sector, specializes in developing antiviral drugs. With a specific focus on health security, SIGA’s flagship product, TPOXX, is designed..

COMPASS Pathways Plc (CMPS) Stock Analysis: Exploring the 120% Upside Potential

Investors have been keeping a keen eye on COMPASS Pathways Plc (NASDAQ: CMPS), a pioneering biotech firm at the forefront of mental health treatment innovation. With a market capitalization of..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Unpacking a 40% Potential Upside

Theravance Biopharma, Inc. (TBPH), a prominent player in the biotechnology sector, is capturing investor attention with its significant potential upside. With a market capitalization of approximately $963.79 million, this South..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Can Investors Expect a 17% Upside?

Cross Country Healthcare, Inc. (NASDAQ: CCRN), a notable player in the healthcare staffing industry, is navigating a challenging landscape marked by fluctuating market conditions and evolving healthcare needs. As an..

EyePoint, Inc. (EYPT) Stock Analysis: Exploring the 111% Upside Potential Amidst Strategic R&D

EyePoint, Inc. (NASDAQ: EYPT), a biotechnology firm with a focus on developing sustained delivery therapeutics for serious retinal diseases, has become a focal point for investors seeking high-growth potential within..

Emergent BioSolutions Inc. (EBS) Stock Analysis: Navigating Through Challenges with Strategic Innovation

Emergent BioSolutions Inc. (NYSE: EBS) continues to stand out in the healthcare sector with its focused dedication to addressing some of the most critical public health threats. With a market..

Surmodics, Inc. (SRDX) Stock Analysis: Navigating Challenges with Strategic Focus in the Medical Device Sector

Surmodics, Inc. (NASDAQ: SRDX) stands at the forefront of the healthcare sector, specifically within the medical devices industry. With a market capitalization of $614.58 million, the company is a key..

Avanos Medical, Inc. (AVNS) Stock Analysis: Healthcare Innovator with 4.3% Revenue Growth and Strategic Market Position

Avanos Medical, Inc. (NYSE: AVNS) stands as a notable player in the healthcare sector, focusing on innovative medical device solutions. With a market capitalization of $569.1 million, Avanos is making..

Septerna, Inc. (SEPN) Stock Analysis: Unraveling a 28.76% Potential Upside in Biotechnology

For investors with an eye on the burgeoning biotechnology sector, Septerna, Inc. (SEPN) presents an intriguing opportunity. This clinical-stage company, headquartered in South San Francisco, California, is making significant strides..

Cogent Biosciences, Inc. (COGT) Stock Analysis: Unlocking a 41% Upside Potential

Investors are turning their focus to Cogent Biosciences, Inc. (NASDAQ: COGT), a biotechnology company that is gaining momentum in the healthcare sector. With a market capitalization of $5.46 billion, Cogent..

MeiraGTx Holdings (MGTX) Stock Report: Analyzing a 267% Upside Potential in the Biotech Sector

Investors with an eye on the biotechnology landscape might find MeiraGTx Holdings plc (NASDAQ: MGTX) a particularly intriguing opportunity. This clinical-stage genetics medicines company is making waves in the healthcare..

Simulations Plus, Inc. (SLP) Stock Analysis: Exploring a 29% Upside Potential in Healthcare Tech

Simulations Plus, Inc. (SLP), a notable player in the healthcare sector, has carved a niche within the health information services industry. Headquartered in Research Triangle Park, North Carolina, the company..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Navigating Opportunities in the Senior Living Market

Sonida Senior Living, Inc. (SNDA), a prominent player in the healthcare sector specializing in medical care facilities, presents a notable opportunity for investors interested in the senior housing market. Based..

Investor Outlook on Personalis, Inc. (PSNL): Analyzing a Potential 31.34% Upside in the Genomics Sector

Personalis, Inc. (NASDAQ: PSNL) is charting a unique course in the burgeoning field of advanced cancer genomics, offering a suite of sophisticated diagnostic tests and services to detect and monitor..

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: Exploring a Potential 264% Upside

Tectonic Therapeutic, Inc. (NASDAQ: TECX), a burgeoning name in the biotechnology sector, has been capturing significant investor attention due to its innovative approach in therapeutic protein and antibody development. Headquartered..

Verastem, Inc. (VSTM) Investor Outlook: Biotech Stock with Over 100% Potential Upside

For investors with a keen interest in the biotechnology sector, Verastem, Inc. (NASDAQ: VSTM) presents a compelling proposition characterized by its focus on innovative cancer treatments. This development-stage biopharmaceutical company,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds